Other Cancer News

Get the latest cancer news and research. Sort by cancer type or read the current headlines to learn what’s happening in the science of cancer detection and treatment, as well as healthy living tips for dealing with cancer.

Oct

20

New Hope On Finding Better Blood Thinners

Warfarin, one of the most inconvenient, dangerous, and disliked drugs in the world, has remained vitally important for more than 50 years. That tells you how much difficulty scientists have had coming up with safer, easier pills to do what warfarin does -- fight life- threatening blood clots.

Oct

19

FDA Approves New Treatment For Advanced Form Of Kidney Cancer

The U.S. Food and Drug Administration today approved Votrient (pazopanib), the sixth drug to be approved for kidney cancer since 2005. Votrient is an oral medication that interferes with angiogenesis, the growth of new blood vessels needed for solid tumors to grow and survive.

Oct

19

Lung Cancer Alliance Launches Shine A Light On Lung Cancer National Vigil

Today, Lung Cancer Alliance (LCA) announced the launch of the Shine a Light National Lung Cancer Vigil, a campaign designed to raise awareness of lung cancer during November, Lung Cancer Awareness Month. Building on the success of vigils held across the country over the past three years, LCA is encouraging an even greater number of volunteers to host a vigil in their community.

Oct

16

NCCN Teams With Discovery Health Channel To Focus On Living With Advanced Non-small Cell Lung Cancer

NCCN program on Discovery Health Channel profiles patients battling advanced non-small cell lung cancer and highlights their physicians' use of the NCCN Guidelines for Non- Small Cell Lung Cancer in determining the best treatment regimen. The program, which provides free CME credits, premieres on Sunday, October 18 at 7:00 am EDT.

Oct

15

Genes Signal Late-Stage Laryngeal Cancer, Poorer Outcome

Researchers at Henry Ford Hospital have identified tumor-suppressing genes that may provide a more accurate diagnosis of disease stage and survival for laryngeal cancer patients than current standards. The study finds genetic abnormalities of the ESR1(estrogen specific receptor 1) gene and the HIC1 (hypermethylated in cancer 1) gene are predictors of late-stage laryngeal cancer and shorter survival, respectively, for patients with the disease.

Oct

15

Studies From National Institutes Of Health Have Provided New Data On Head And Neck Cancer Risk Factors

Data detailed in 'Total exposure and exposure rate effects for alcohol and smoking and risk of head and neck cancer: a pooled analysis of case- control studies' have been presented. Although cigarette smoking and alcohol consumption increase risk for head and neck cancers, there have been few attempts to model risks quantitatively and to formally evaluate cancer site-specific risks.

Oct

15

Inventive Combination Of Research Approaches Identifies New Target For Treating Leukemia

New research integrates sophisticated interdisciplinary approaches to solve a molecular mystery that may lead to alternative therapeutic strategies for acute myeloid leukemia (AML). The study, published by Cell Press in the October issue of the journal Cancer Cell, identifies a previously unrecognized AML target that responds well to pharmacological inhibition and may be an excellent candidate for use in future clinical trials.

Oct

13

Minimally Invasive Device Approved To Treat Liver Cancer, Fibroids, Tumors, And Bleeding

CeloNova BioSciences, Inc. has received approval from its European regulatory body, the British Standards Institution, to expand the list of medical indications for which Embozene(TM) Microspheres may be used and to add a tenth size of the product.

Oct

08

Lack Of Social Interaction Affects Health Outcomes Of Breast Cancer

Social environment can play an important role in the biology of disease, including breast cancer, and lead to significant differences in health outcome, according to results of a study published in Cancer Prevention Research, a journal of the American Association for Cancer Research.

Oct

08

New Research On Vascular Endothelial Growth Factor From Brain Tumor Center Summarized

According to a study from the United States, Preclinical studies suggest that inhibition of vascular endothelial growth factor (VEGF) improves glioma response to radiotherapy. Bevacizumab, a monoclonal antibody against VEGF, has shown promise in recurrent gliomas, but the safety and efficacy of concurrent bevacizumab with brain irradiation has not been extensively studied.

Page(s): Prev 1 2 3 4 5 6 7 ...539540 Next 

We care about your feedback. Let us know how we can improve your CancerCompass experience.